|
Sponsored by
The Pharmaceutical
Compliance Forum
|
SEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
Transformational Learning - Effective Knowledge Exchange
JW Marriott Hotel
Washington, DC
November, 8 - 10, 2006
|
|
CONGRESS CD-ROM AND iPOD NOW AVAILABLE!
CD-ROM Interactive Video and and Video iPOD from the Seventh Pharmaceutical Regulatory and Compliance Congress.
Click here to order yours! |
|
CD-ROM PACKAGE OF RELATED CONFERENCES ALSO AVAILABLE!
|
For just $395, get a package of three CD-ROMs that include these 2006 conferences:
Click here to order yours!
|
|
|
|
CONGRESS CO CHAIRS
|
Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company
|
|
Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC
|
|
|
|
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ
|
|
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP, Stamford, CT
|
|
|
|
|
|
KEYNOTE SPEAKERS
|
Randy Cohen
Author, "The Ethicist" column, The New York Times Magazine, New York, NY
|
|
Michael K. Loucks, Esq.
First Assistant U.S. Attorney, U.S. Attorney's Office for the District of Massachusetts, Boston, MA
|
|
Lewis Morris, Esq.
Chief Counsel, Office of Inspector General, Department of Health and Human Services, Washington, DC
|
|
Eric M. Blumberg, Esq.
Deputy Associate, Office of Chief Counsel, Office of the Commissioner, Food and Drug Administration, Washington, DC
|
|
|
|
Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University, Princeton, NJ
|
|
Jim Sheehan, Esq.
Assistant US Attorney, United States Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA
|
|
P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman, Merck & Co., Bedminster, NJ
|
|
Sherron S. Watkins
Former Vice President, Enron Corporation, Author, Power Failure, the Inside Story of the Collapse of Enron, TIME Magazine 2002 Person of the Year, Glamour Magazine, 2002 Women of the Year, Court TV Scales of Justice Award and Everyday Hero's Award, Houston, TX
|
|
|
|
|
FEATURING THE FOLLOWING SPECIAL SESSIONS AND ACTIVITIES
|
- Pharmaceutical Compliance Primer
- Annual State of the Pharmaceutical Compliance Enterprise Address by Bert Weinstein, Esq., Vice President, Corporate Compliance, Purdue Pharma LP
- Overview of OIG Pharma Compliance Initiatives and Regulators Roundtable
- PCF Compliance Survey Results on Medical Affairs and Marketing, Drug Safety and Pharmacovigilence, and Managing your Compliance Program
- Presentation of PCF First Annual Compliance Best Practice Awards
- Pharma Congress Hypothetical Compliance Vignettes and Response by Panel of Compliance Experts
- Pharmaceutical Compliance Family Feud - The Game with Real Life Implications for the Nation's Pharmaceutical Manufacturers
- Monday Company Best Auditing, Monitoring and Investigations Policy and Procedure Poster Board and Exchange Networking Reception
- Tuesday Meet the Regulator Networking Reception
- Compliance in a Highly Litigious World: Creating Good Documents and Avoiding Bad Ones
- Advanced Tactics for Negotiation with the Government and Preparing for a CIA
- Self Assessments: Adding Value to Your Compliance Program
- The Special Concerns of Small Cap Companies: Building a Compliance Program with Limited Resources
- Death by a Thousand Paper Cuts: State Laws and Pharmaceutical Companies
- Qui Tam Suits: The Barometer of Future Enforcement Actions
- Best Practices in Compliance Program Auditing
- Managing Compliance through Technology
- Integrating Compliance with Business: Developing a Business-Facing Compliance Program
- Compliance Branding
- Off Label Controls and Monitoring
- Fair Market Value: Where, When and How to Use It
- Kickbacks: How to Develop Internal Monitoring Programs
- Grants, CME and Compliance
- FCPA and Other International Compliance Issues
- Compliance vs. the Law Department: How to Work Together
|
|
PCF PHARMA CONGRESS PLANNING COMMITTEE
|
Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company (Co chair)
Arjun Rajaratnam
Vice President and Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline (Co chair)
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation (Co chair)
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP (Co chair)
Ted Acosta
Principal, Ernst & Young LLP
John Alivernini, Esq.
Vice President and Chief, Compliance Officer, Wyeth Pharmaceuticals
David Beardsley
General Manager, Life Sciences, HCPro, Inc.
John T. Bentivoglio, Esq.
Partner, King & Spalding LLP
David B. Chandler, Ph.D., DABT
Associate Director of Outcomes and Analysis Corporate Compliance, Amgen
William T. Fitzgerald
Vice President, Global Compliance, Alcon Laboratories
Robert A. Freeman
US Compliance Officer and Compliance Counsel, Serono, Inc.
Wendy C. Goldstein, Esq.
Partner, Epstein Becker & Green
Peter N. Grant, JD, Ph.D.
President, Health Care Conference Administrators, LLC
Keith M. Korenchuk, JD, MPH
Covington & Burling LLP
Steve Mohr, Esq.
Deputy Compliance Officer, AstraZeneca
Jody Noon, RN, JD
National Leader for the Life Sciences & Health Care Regulatory Practice, Deloitte & Touche LLP
Brian Riewerts
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP
Catherine Sazdanoff
Divisional Vice President, Ethics and Compliance, Abbott Laboratories
Michael Shaw
Deputy Compliance Officer, Novartis Pharmaceuticals Corporation
Paul J. Silver
Managing Director, Huron Consulting Group
Jonathan K. Sprole
Chief Compliance Officer, Bristol-Myers Squibb Company
|
|
|
|
|
SPONSORED BY:
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
COSPONSORED BY:
|
|
ASSOCIATIONS
|
|
|
PUBLICATIONS
|
|
|
|
